Using a sensing vest to guide care after a heart attack
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial tests a new, non-invasive vest-like device (ReDS) that measures fluid in the lungs of people who had a heart attack and then developed heart failure symptoms after their procedure. It helps doctors monitor fluid levels to improve recovery and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and currently in the hospital for a heart attack.
- After a procedure to reopen a blocked heart artery, you must have symptoms of fluid overload, like swelling or trouble breathing.
- Your heart-failure blood test (BNP or NT-proBNP) must be above a certain level.
- You must be between 155 and 190 cm (about 5'1" to 6'3") tall and have a body mass index (BMI) between 22 and 39.
- You must not have chronic lung disease, a mechanical heart pump, a heart transplant, or certain heart defects.
- You must not be on dialysis for kidney failure or have other life-limiting conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a sensor that monitors oxygen levels in body tissues to help doctors spot when your heart is not pumping enough blood early. The goal is to catch problems sooner so you can get faster treatment.
This trial tests if using a wearable monitor (ReDS) to guide fluid removal helps people hospitalized for heart failure. The goal is to find the right amount of fluid to remove so patients feel better and stay out of the hospital.
This study tests a wearable vest that measures fluid in your lungs to help doctors adjust water-pill treatments for heart failure. It aims to reduce hospital stay and improve recovery.
This study tests a wearable vest that measures fluid in your lungs without needles. It helps doctors adjust your IV diuretics (water pills) during a hospital stay for heart failure, aiming for more personalized treatment and faster recovery.
This study uses a noninvasive device (ReDS) to estimate fluid buildup in people hospitalized with acute heart failure. It may help doctors monitor fluid status and guide care more accurately during a hospital stay.
This trial tests a new device that measures fluid in your lungs without needles or surgery. It may help your doctor manage heart failure better, especially if you've been in the hospital recently or have symptoms like shortness of breath.
Hear when a new Acute Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.